StudentShare
Contact Us
Sign In / Sign Up for FREE
Search
Go to advanced search...
Free

Business Strategy for Nucleon - Essay Example

Cite this document
Summary
In the essay “Business Strategy for Nucleon” the author tries to answer the question whether Nucleon should consider vertical integration by operating its own pilot plant or whether, in view of the largest financial outlay, it should contract or license out the operations…
Download full paper File format: .doc, available for editing
GRAB THE BEST PAPER91% of users find it useful
Business Strategy for Nucleon
Read Text Preview

Extract of sample "Business Strategy for Nucleon"

Business Strategy for Nucleon Phase I and II Clinical trials: The basis question that arises during this stage is whether Nucleon should consider vertical integration by operating its own pilot plant and investing in its development or whether, in view of the largest financial outlay, it should contract or license out the operations? The extent to which a firm owns its upstream and downstream suppliers and buyers respectively is vertical integration. Two issues that must be considered when deciding whether or not to integrate are cost and control. One important consideration in Phase I and II is that the processes required during the first two phases are so intricate and specialized that there are many problems that could arise and production processes need to be very tightly controlled. Bio technology processes are an art and processes can fail when transferred from one facility to another, largely due to the differences in little things which are minor elements, yet make a huge difference in the output. This favors Nucleon building its own plant which means higher costs and more time, although it also implies greater control. Contracting also involves more time and an estimated expense of about 4 million dollars. Moreover, there is the danger of confidential information about manufacturing leaking out, although it would free Nucleon’s R&D people to focus exclusively on their specialty which is research – this is also the factor that has propelled Nucleon to the top. However, in my view, vertical integration is not favored in this case. The reason is that Phase I and II trials are still an experimental stage of development of the drug and all investments made on the pilot plant could be lost, while also deflecting funds from other research work. Contracting out is not a good option due to loss of confidentiality. However the licensing option offers an excellent situation because it allows risks associated with clinical trials and expenses related to development, marketing and sales of the drug to a third Company, while also protecting Nucleon’s patent on the product. This will allow the Company to focus on its core competencies, i.e, research and development. One of the developments in management theory is the belief that most firms have only a few “core competencies” where they possess exceptional skills and abilities, therefore in order to sustain a competitive advantage in an increasingly cut throat global economy, it is better to hire firms with their own core competencies to perform other tasks that are required as a part of organizational activity.(Prahalad and Hamel, 1990). Therefore, it may be better for Nucleon to allow another Company which specializes in manufacturing to enter into this activity rather than taking it up itself. This also provides an opportunity for the licensee company to enter into the production process at an early stage to familiarize itself with the intricacies of the production process. Nucleon would receive $3 million and a share in royalties from all sales if the product is approved, without incurring any of the financial risks involved. Phase III: Vertical integration is not favored at the pilot stage either. It may be noted that Nucleon has already entered into agreements with another company on marketing, largely because it is difficult for it to sustain a competitive advantage by taking this on itself. Nucleon employees would have to develop new competencies, which could compromise their existing competencies. Secondly, there is a huge financial outlay, which may or may not be recovered in the intensely competitive drug market. It would also result in decreased flexibility for Nucleon in financial outlays for future projects. The fallacy with the advantages of the “make” policy of vertical integration is that it ignores the opportunity costs inherent in sales in the outside market (vertical boundaries). Since the drug market is volatile and subject to fluctuations, it could be more advantageous for Nucleon to enter into a partnership/licensing arrangement with one Company for manufacturing and marketing, which will mitigate its own risks, while allowing it to benefit from its product, with another Company bearing the risks. In fact, Nucleon would be able to receive a $7 million payment and 10% of the partner’s gross sales without investing any capital outlays. It must be admitted that Nucleon’s profits may not be as high as they would be if it integrated vertically and took up manufacturing activity. However, the financial risks are also greater, especially in the volatile drug market. It must also be borne in mind that there are already other Companies that are working on patents for CRP products so any advantage Nucelon has would be minimal at best and its best advantages will be for a short period in the initial stages when its product is still new. In a competitive market, another Company would be faced with the risks and challenges in sustaining that advantage while Nucleon could focus on developing more products. Financial implications and risks: The strategy I have recommended involves minimal risk for the Company, which is still not a fully established large scale concern. There is no capital outlay involved at all, rather Nucleon stands to gain $10 million upfront, which will provide much needed funds to continue pioneering research work and also earn a continuous, though modest stream of income from royalties and sales of its products. When the Company has established itself as a more solid financial concern in a few years time, it could consider integrating into commercial manufacturing on its other products. However, in view of the fact that it is a relatively new Company, it may be a better strategy to focus on its core competencies – i.e, research and development, in order to build and sustain a competitive advantage in the market. There is greater interest in the market in genetic companies and the kind of products that Nucleon is manufacturing, however if the competencies of its research scientists is divided into manufacturing, there may be an impairment of both manufacturing and research activities with the Company suffering an overall negative effect. After ten years: Although I have not recommended vertical integration for this particular product, I do however support the integration strategy for Nucleon on a long term basis. However, I would not recommend that it moves into a fully integrated enterprise, since it will significantly lessen its ability to develop a variety of new products. In today’s global marketplace, creativity and innovation have assumed a great deal of importance and it is important for a Company to have a fresh and novel strategy if it is to succeed in the market place, as identified by Porter (1996: 68). “Competitive strategy is about being different.” (Porter,1996:64). Porter also states that “Strategy is the creation of a unique and valuable position, involving a different set of activities……different from rivals.” (page Porter 1996: 68). Therefore, Nucleon’s strength will be in its research facilities and skills and this should not be compromised. However, the Company can certainly consider branching out into pilot scale manufacturing capabilities, because investments in fixed assets such as buildings, etc can be applied over a period of time in the development of several different products, allowing the Company to earn more income but in a manner that will not be a source of significant financial risks. References: * Porter, M.E. (1996), What is Strategy? Harvard Business Review, Nov-Dec.: 61-78. * Prahalad, C.K. and Hamel, G. (1990). “The core competence of the Corporation” Harvard Business Review (May-June):79-91 * The Vertical Boundaries of the Firm Read More
Cite this document
  • APA
  • MLA
  • CHICAGO
(“Business Strategy for Nucleon Essay Example | Topics and Well Written Essays - 1000 words”, n.d.)
Business Strategy for Nucleon Essay Example | Topics and Well Written Essays - 1000 words. Retrieved from https://studentshare.org/management/1542274-mba-case-study
(Business Strategy for Nucleon Essay Example | Topics and Well Written Essays - 1000 Words)
Business Strategy for Nucleon Essay Example | Topics and Well Written Essays - 1000 Words. https://studentshare.org/management/1542274-mba-case-study.
“Business Strategy for Nucleon Essay Example | Topics and Well Written Essays - 1000 Words”, n.d. https://studentshare.org/management/1542274-mba-case-study.
  • Cited: 0 times

CHECK THESE SAMPLES OF Business Strategy for Nucleon

Electrical Power from Nuclear Source: Ecological Challenges and Economic Benefits

This research aims to evaluate and present Ecological Challenges and Economic Benefits of the Electrical Power from Nuclear Source.... This research is the best example of comparison and contrast the Economics of the Different Forms of Electricity Generation Systems.... … According to the discussion nuclear power is a safe form of power if environmental aspects of the coal generated power is considered, particular emissions are considered like the carbon and sulphur emissions are considered....
39 Pages (9750 words) Dissertation

Investigating The International Strategy Of A Chosen MNE. The lectricit de France

The research paper will focus upon the international expansion strategy in India.... However, the MNCs need to consider these uncertainties as challenges and decide its strategy accordingly (Jannson, 2008).... The company has an excellent business model where a proper balance has been maintained between the regulated and the non regulated activities (EDF, 2009).... The emerging countries such as India have become an important ground for the international business activities of the multinational corporations....
16 Pages (4000 words) Essay

Nuclear Arms Race is better than Nuclear Arms Reduction for World Peace

At present times, the nuclear race is becoming a strategy for the world peace and harmony as several countries are signing the treaties on non-spreading and non-propagation of the nuclear weaponries (Alexander & Millar, 2003).... “The nuclear arms and weapons race demonstrates and illustrates the fact that the nuclear arm came under design to create destruction and gain economic, political power over others, however, this theory has now eradicated, and a peace strategy comes under correlation to the nuclear arm race” (Gaddis, 2006)....
2 Pages (500 words) Assignment

Mergers and acquisitions process

Despite these findings, companies continue to adopt an M&A strategy for several reasons.... Mergers and acquisitions (M&A) involve a bidding (buying) firm buying a target firm and are a way for companies to grow through a strategy of corporate diversification and vertical integration.... Empirical evidence shows that an M&A strategy is more successful if both firms are strategically related than unrelated.... The fifth reason is the bidding firm might gain some benefits by implementing the M&A strategy that, by putting two firms together, may result in valuable, rare, and costly to imitate advantages....
4 Pages (1000 words) Essay

Global Corporate Strategy

he report starts with an understanding of the terms corporate planning and strategy.... The Nuclear Energy Agency has estimated that the demand for electricity would jump 2.... times by 2050.... It has also been predicted that between 2030 and 2050, the energy requirement of the world would increase many times and… As far as UK is concerned, it is expected to produce electricity equivalent to one billion oil barrels by 2050....
12 Pages (3000 words) Essay

International Business Strategy

Among such examples of crucial decisions that managers usually face in their line of work include which marketing strategy to apply or whether to venture into a new market or not.... Secondly, it will involve the use of various analytical tools that test different parameters that can determine the viability of a business decision or option.... According to Porter, a business is usually influenced by the prevailing situation in the market, which can as well contribute to its success or failure in the marketplace....
9 Pages (2250 words) Essay

Strategic Management - GE

This strategy utilizes three stakeholders' strategic elements such as managing strong trading patterns, increasing growth efforts, and increasing business portfolio (Kaye &Yuwono, 2003).... This strategy is based on several factors including customer focus, globalization, growth platforms, technical leadership, and services.... Diversification strategy has proved to be not only a source of the company's competitive advantage but also a barrier to entry Aron (2011), Bartlett (2006), Franke et al (2003) and Grant (2008)....
2 Pages (500 words) Essay

The Core Business Activity: Cameco Corporation

In the paper “The Core business Activity: Cameco Corporation” the author focuses on Cameco Corporation, which has its headquarters in Saskatoon, Canada, and commenced operations in 1987.... Cameco is a dominant player in the field of uranium production by being the world's largest low-cost uranium producer....
7 Pages (1750 words) Assignment
sponsored ads
We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.
Contact Us